Eslam M, Sanyal AJ, George J, an international consensus p. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999–2014.
Kopec AK, Joshi N, Towery KL, Kassel KM, Sullivan BP, Flick MJ, et al. Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. J Pharmacol Exp Ther. 2014;351:288–97.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lu H. Crosstalk of HNF4alpha with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids. Acta Pharm Sin B. 2016;6:393–408.
Article
PubMed
PubMed Central
Google Scholar
Xu Y, Zalzala M, Xu J, Li Y, Yin L, Zhang Y. A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism. Nat Commun. 2015;6:7466.
Article
CAS
PubMed
Google Scholar
Li T, Jahan A, Chiang JY. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology. 2006;43:1202–10.
Article
CAS
PubMed
Google Scholar
Xie X, Liao H, Dang H, Pang W, Guan Y, Wang X, et al. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs. Mol Endocrinol. 2009;23:434–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Longo M, Crosignani A, Podda M. Hyperlipidemia in Chronic Cholestatic Liver Disease. Curr Treat Options Gastroenterol. 2001;4:111–4.
Article
PubMed
Google Scholar
Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28:155–61.
Article
PubMed
CAS
Google Scholar
Lim S, Taskinen MR, Boren J. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obes Rev. 2019; 20:599–611.
Privitera G, Spadaro L, Marchisello S, Fede G, Purrello F. Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance. Dig Dis Sci. 2018;63:16–26.
Article
CAS
PubMed
Google Scholar
Florentino RM, Fraunhoffer NA, Morita K, Takeishi K, Ostrowska A, Achreja A, et al. Cellular Location of HNF4alpha is Linked With Terminal Liver Failure in Humans. Hepatol Commun. 2020;4:859–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lu H, Gonzalez FJ, Klaassen C. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. Toxicol Sci. 2010;118:380–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001;21:1393–403.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ishida H, Kuruta Y, Gotoh O, Yamashita C, Yoshida Y, Noshiro M. Structure, evolution, and liver-specific expression of sterol 12alpha-hydroxylase P450 (CYP8B). J Biochem. 1999;126:19–25.
Article
CAS
PubMed
Google Scholar
Takahashi S, Fukami T, Masuo Y, Brocker CN, Xie C, Krausz KW, et al. Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. J Lipid Res. 2016;57:2130–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen J, Zhao KN, Chen C. The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis. Ann Transl Med. 2014;2:7.
PubMed
PubMed Central
Google Scholar
Li T, Apte U. Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer. Adv Pharmacol. 2015;74:263–302.
Article
PubMed
PubMed Central
CAS
Google Scholar
Honda A, Miyazaki T, Iwamoto J, Hirayama T, Morishita Y, Monma T, et al. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. J Lipid Res. 2020;61:54–69.
Article
CAS
PubMed
Google Scholar
Song C, Hiipakka RA, Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids. 2000;65:423–7.
Article
CAS
PubMed
Google Scholar
Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav Immun. 2005;19:275–80.
Article
PubMed
Google Scholar
Ahmed A, Rabbitt E, Brady T, Brown C, Guest P, Bujalska IJ, et al. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. PLoS One. 2012;7:e29531.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nasiri M, Nikolaou N, Parajes S, Krone NP, Valsamakis G, Mastorakos G, et al. 5alpha-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes. Endocrinology. 2015;156:2863–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lemke U, Krones-Herzig A, Berriel Diaz M, Narvekar P, Ziegler A, Vegiopoulos A, et al. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab. 2008;8:212–23.
Article
CAS
PubMed
Google Scholar
Roqueta-Rivera M, Esquejo RM, Phelan PE, Sandor K, Daniel B, Foufelle F, et al. SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a Regulation. Cell Metab. 2016;24:474–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
John K, Marino JS, Sanchez ER, Hinds TD Jr. The glucocorticoid receptor: cause of or cure for obesity? Am J Physiol Endocrinol Metab. 2016;310:E249–57.
Article
PubMed
Google Scholar
Montagner A, Polizzi A, Fouche E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Regnier M, Lukowicz C, Benhamed F, et al. Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut. 2016;65:1202–14.
Article
CAS
PubMed
Google Scholar
Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 2000;14:2819–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4alpha in adult mice. J Biol Chem. 2012;287:7345–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 2010;52:934–44.
Article
CAS
PubMed
Google Scholar
Mittelstadt PR, Monteiro JP, Ashwell JD. Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness. J Clin Invest. 2012;122:2384–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Navarre J, Bradford AJ, Calhoun BC, Goldenring JR. Quenching of endogenous peroxidase in western blot. Biotechniques. 1996;21:990–2.
Article
CAS
PubMed
Google Scholar
Zhang Y, Li D, Sun B. Do housekeeping genes exist? PLoS One. 2015;10:e0123691.
Article
PubMed
PubMed Central
CAS
Google Scholar
Falkenberg VR, Whistler T, Murray JR, Unger ER, Rajeevan MS. Identification of Phosphoglycerate Kinase 1 (PGK1) as a reference gene for quantitative gene expression measurements in human blood RNA. BMC Res Notes. 2011;4:324.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lu H, Cui W, Klaassen CD. Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis. Toxicol Appl Pharmacol. 2011;256:122–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bathena SP, Mukherjee S, Olivera M, Alnouti Y. The profile of bile acids and their sulfate metabolites in human urine and serum. J Chromatogr B Anal Technol Biomed Life Sci. 2013;942-943:53–62.
Article
CAS
Google Scholar
Huang J, Bathena SP, Csanaky IL, Alnouti Y. Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC-MS/MS. J Pharm Biomed Anal. 2011;55:1111–9.
Article
CAS
PubMed
Google Scholar
Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res. 1989;30:719–30.
Article
CAS
PubMed
Google Scholar
Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol. 2009;15:804–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coffinier C, Gresh L, Fiette L, Tronche F, Schutz G, Babinet C, et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development. 2002;129:1829–38.
Article
CAS
PubMed
Google Scholar
Qu X, Lam E, Doughman YQ, Chen Y, Chou YT, Lam M, et al. Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J. 2007;26:4445–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu P, Wang Y, Du Y, He L, Huang G, Zhang G, et al. C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling. Nat Commun. 2015;6:7122.
Article
CAS
PubMed
Google Scholar
Tchorz JS, Kinter J, Muller M, Tornillo L, Heim MH, Bettler B. Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice. Hepatology. 2009;50:871–9.
Article
CAS
PubMed
Google Scholar
Adams JM, Jafar-Nejad H. The Roles of Notch Signaling in Liver Development and Disease. Biomolecules. 2019;9:608.
Dwyer BJ, Olynyk JK, Ramm GA, Tirnitz-Parker JE. TWEAK and LTbeta Signaling during Chronic Liver Disease. Front Immunol. 2014;5:39.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hwang-Verslues WW, Sladek FM. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol. 2008;22:78–90.
Article
CAS
PubMed
Google Scholar
Chang B, Xu MJ, Zhou Z, Cai Y, Li M, Wang W, Feng D, Bertola A, Wang H, Kunos G, Gao B. Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1. Hepatology. 2015;62:1070–85.
Article
CAS
PubMed
Google Scholar
Gehrke N, Hovelmeyer N, Waisman A, Straub BK, Weinmann-Menke J, Worns MA, et al. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation. J Hepatol. 2018;68:986–95.
Article
CAS
PubMed
Google Scholar
Meng J, Feng M, Dong W, Zhu Y, Li Y, Zhang P, et al. Identification of HNF-4alpha as a key transcription factor to promote ChREBP expression in response to glucose. Sci Rep. 2016;6:23944.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015;5:135–44.
Article
PubMed
PubMed Central
Google Scholar
Magee N, Zou A, Ghosh P, Ahamed F, Delker D, Zhang Y. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis. J Biol Chem. 2020;295:994–1008.
Article
PubMed
Google Scholar
Sheng L, Cho KW, Zhou Y, Shen H, Rui L. Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid beta-oxidation. J Biol Chem. 2011;286:38128–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Melander O. Vasopressin, from Regulator to Disease Predictor for Diabetes and Cardiometabolic Risk. Ann Nutr Metab. 2016;68(Suppl 2):24–8.
Article
PubMed
Google Scholar
Hiroyama M, Aoyagi T, Fujiwara Y, Birumachi J, Shigematsu Y, Kiwaki K, et al. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol Endocrinol. 2007;21:247–58.
Article
CAS
PubMed
Google Scholar
Longuet C, Robledo AM, Dean ED, Dai C, Ali S, McGuinness I, et al. Liver-specific disruption of the murine glucagon receptor produces alpha-cell hyperplasia: evidence for a circulating alpha-cell growth factor. Diabetes. 2013;62:1196–205.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shao YX, Huang M, Cui W, Feng LJ, Wu Y, Cai Y, et al. Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent. J Med Chem. 2014;57:10304–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Krakowiak PA, Wassif CA, Kratz L, Cozma D, Kovarova M, Harris G, Grinberg A, Yang Y, Hunter AG, Tsokos M, et al. Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum Mol Genet. 2003;12:1631–41.
Article
CAS
PubMed
Google Scholar
Mutch DM, Klocke B, Morrison P, Murray CA, Henderson CJ, Seifert M, et al. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism. J Proteome Res. 2007;6:3976–84.
Article
CAS
PubMed
Google Scholar
Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, Yang W, Zhang L, Ding X. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem. 2003;278:25895–901.
Article
CAS
PubMed
Google Scholar
Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JY. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology. 2010;52:678–90.
Article
CAS
PubMed
Google Scholar
Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation. J Biol Chem. 2004;279:2480–9.
Article
CAS
PubMed
Google Scholar
Feng L, Yuen YL, Xu J, Liu X, Chan MY, Wang K, et al. Identification and characterization of a novel PPARalpha-regulated and 7alpha-hydroxyl bile acid-preferring cytosolic sulfotransferase mL-STL (Sult2a8). J Lipid Res. 2017;58:1114–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Csanaky IL, Lu H, Zhang Y, Ogura K, Choudhuri S, Klaassen CD. Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice. Hepatology. 2011;53:272–81.
Article
CAS
PubMed
Google Scholar
Takiguchi S, Ayaori M, Yakushiji E, Nishida T, Nakaya K, Sasaki M, et al. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways. Arterioscler Thromb Vasc Biol. 2018;38:1454–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tao H, Aakula S, Abumrad NN, Hajri T. Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Am J Physiol Endocrinol Metab. 2010;298:E68–79.
Article
CAS
PubMed
Google Scholar
Plump AS, Azrolan N, Odaka H, Wu L, Jiang X, Tall A, et al. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. J Lipid Res. 1997;38:1033–47.
Article
CAS
PubMed
Google Scholar
Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci U S A. 1996;93:14788–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hotta Y, Nakamura H, Konishi M, Murata Y, Takagi H, Matsumura S, et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology. 2009;150:4625–33.
Article
CAS
PubMed
Google Scholar
Chiu HK, Qian K, Ogimoto K, Morton GJ, Wisse BE, Agrawal N, et al. Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis. Endocrinology. 2010;151:993–1001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A. 2001;98:7522–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reid BN, Ables GP, Otlivanchik OA, Schoiswohl G, Zechner R, Blaner WS, et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem. 2008;283:13087–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. Endocrinology. 2016;157:570–85.
Article
CAS
PubMed
Google Scholar
Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509:503–6.
Article
CAS
PubMed
Google Scholar
Carr RM, Ahima RS. Pathophysiology of lipid droplet proteins in liver diseases. Exp Cell Res. 2016;340:187–92.
Article
CAS
PubMed
Google Scholar
Najt CP, Senthivinayagam S, Aljazi MB, Fader KA, Olenic SD, Brock JR, et al. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Am J Physiol Gastrointest Liver Physiol. 2016;310:G726–38.
Article
PubMed
PubMed Central
Google Scholar
Gross DA, Zhan C, Silver DL. Direct binding of triglyceride to fat storage-inducing transmembrane proteins 1 and 2 is important for lipid droplet formation. Proc Natl Acad Sci U S A. 2011;108:19581–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kadereit B, Kumar P, Wang WJ, Miranda D, Snapp EL, Severina N, et al. Evolutionarily conserved gene family important for fat storage. Proc Natl Acad Sci U S A. 2008;105:94–9.
Article
CAS
PubMed
Google Scholar
Franklin MP, Sathyanarayan A, Mashek DG. Acyl-CoA Thioesterase 1 (ACOT1) Regulates PPARalpha to Couple Fatty Acid Flux With Oxidative Capacity During Fasting. Diabetes. 2017;66:2112–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A. 2003;100:4012–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Niemi NM, Wilson GM, Overmyer KA, Vogtle FN, Myketin L, Lohman DC, et al. Pptc7 is an essential phosphatase for promoting mammalian mitochondrial metabolism and biogenesis. Nat Commun. 2019;10:3197.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ochoa-Sanchez R, Rose CF. Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease. J Clin Exp Hepatol. 2018;8:262–71.
Article
PubMed
PubMed Central
Google Scholar
Besse A, Wu P, Bruni F, Donti T, Graham BH, Craigen WJ, et al. The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism. Cell Metab. 2015;21:417–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hata T, Rehman F, Hori T, Nguyen JH. GABA, gamma-Aminobutyric Acid, Protects Against Severe Liver Injury. J Surg Res. 2019;236:172–83.
Article
CAS
PubMed
Google Scholar
Sato M, Kawakami T, Kondoh M, Takiguchi M, Kadota Y, Himeno S, et al. Development of high-fat-diet-induced obesity in female metallothionein-null mice. FASEB J. 2010;24:2375–84.
Article
CAS
PubMed
Google Scholar
Waller-Evans H, Hue C, Fearnside J, Rothwell AR, Lockstone HE, Calderari S, et al. Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome. PLoS One. 2013;8:e82825.
Article
PubMed
PubMed Central
CAS
Google Scholar
Thomas AM, Hart SN, Li G, Lu H, Fang Y, Fang J, et al. Hepatocyte nuclear factor 4 alpha and farnesoid X receptor co-regulates gene transcription in mouse livers on a genome-wide scale. Pharm Res. 2013;30:2188–98.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chypre M, Zaidi N, Smans K. ATP-citrate lyase: a mini-review. Biochem Biophys Res Commun. 2012;422:1–4.
Article
CAS
PubMed
Google Scholar
Chella Krishnan K, Floyd RR, Sabir S, Jayasekera DW, Leon-Mimila PV, Jones AE, et al. Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner. Cell Mol Gastroenterol Hepatol. 2021;11:389–406.
Zhang M, Zhao Y, Li Z, Wang C. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis. Biochem Biophys Res Commun. 2018;495:582–6.
Article
CAS
PubMed
Google Scholar
She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol. 2000;20:6508–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu Y, Zhao S, Deng Y, Gordillo R, Ghaben AL, Shao M, et al. Hepatic GALE Regulates Whole-Body Glucose Homeostasis by Modulating Tff3 Expression. Diabetes. 2017;66:2789–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A. 1999;96:11041–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes. J Biol Chem. 2002;277:37254–9.
Article
CAS
PubMed
Google Scholar
Chapman K, Holmes M, Seckl J. 11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013;93:1139–206.
Article
CAS
PubMed
PubMed Central
Google Scholar
Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V, et al. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur J Endocrinol. 2000;142:200–7.
Article
CAS
PubMed
Google Scholar
Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta. 1812;2011:893–908.
Google Scholar
Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004;113:1408–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Iordanidou P, Aggelidou E, Demetriades C, Hadzopoulou-Cladaras M. Distinct amino acid residues may be involved in coactivator and ligand interactions in hepatocyte nuclear factor-4alpha. J Biol Chem. 2005;280:21810–9.
Article
CAS
PubMed
Google Scholar
Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol. 2000;20:187–95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stafford JM, Wilkinson JC, Beechem JM, Granner DK. Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem. 2001;276:39885–91.
Article
CAS
PubMed
Google Scholar
Onica T, Nichols K, Larin M, Ng L, Maslen A, Dvorak Z, et al. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter. Mol Pharmacol. 2008;73:451–60.
Article
CAS
PubMed
Google Scholar
Patel R, Bookout AL, Magomedova L, Owen BM, Consiglio GP, Shimizu M, et al. Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop. Mol Endocrinol. 2015;29:213–23.
Article
PubMed
CAS
Google Scholar
Ratman D, Mylka V, Bougarne N, Pawlak M, Caron S, Hennuyer N, et al. Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARalpha. Nucleic Acids Res. 2016;44:10539–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kimura H. Histone modifications for human epigenome analysis. J Hum Genet. 2013;58:439–45.
Article
CAS
PubMed
Google Scholar
Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez-Alvarez A, Alvarez MS, Gonzalez R, Cucarella C, Muntane J, Casado M. Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem. 2011;286:21466–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson MC, Palmer CN, McLauchlan J. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta. 1728;2005:95–104.
Google Scholar
Edvardsson U, Ljungberg A, Linden D, William-Olsson L, Peilot-Sjogren H, Ahnmark A, et al. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes. J Lipid Res. 2006;47:329–40.
Article
CAS
PubMed
Google Scholar
Sato O, Kuriki C, Fukui Y, Motojima K. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J Biol Chem. 2002;277:15703–11.
Article
CAS
PubMed
Google Scholar
Rulcova A, Krausova L, Smutny T, Vrzal R, Dvorak Z, Jover R, et al. Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4alpha upregulation in primary human hepatocytes. Pharmacol Rep. 2013;65:1322–35.
Article
CAS
PubMed
Google Scholar
Snyers L, De Wit L, Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci U S A. 1990;87:2838–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goswami R, Lacson R, Yang E, Sam R, Unterman T. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter. Endocrinology. 1994;134:736–43.
Article
CAS
PubMed
Google Scholar
Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006;4:199–210.
Article
CAS
PubMed
Google Scholar
Rajwani A, Ezzat V, Smith J, Yuldasheva NY, Duncan ER, Gage M, et al. Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes. 2012;61:915–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu M, Yin H, Mitra MS, Liang X, Ajmo JM, Nadra K, et al. Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice. Hepatology. 2013;58:1953–63.
Article
CAS
PubMed
Google Scholar
Gautier-Stein A, Soty M, Chilloux J, Zitoun C, Rajas F, Mithieux G. Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1alpha with CREB-binding protein. Diabetes. 2012;61:2451–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang X, Heckmann BL, Campbell LE, Liu J. G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux. Biochim Biophys Acta Mol Cell Biol Lipids. 1862;2017:1146–54.
Google Scholar
Burke AC, Huff MW. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia. Curr Opin Lipidol. 2017;28:193–200.
Milona A, Massafra V, Vos H, Naik J, Artigas N, Paterson HAB, et al. Steroidogenic control of liver metabolism through a nuclear receptor-network. Mol Metab. 2019;30:221–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jia Y, Ji P, French SW. The Role of FAT10 in Alcoholic Hepatitis Pathogenesis. Biomedicines. 2020;8:189.
Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol. 2012;227:493–507.
Article
CAS
PubMed
PubMed Central
Google Scholar
Levine JA, Oleaga C, Eren M, Amaral AP, Shang M, Lux E, et al. Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep. 2021;11:430.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beier JI, Arteel GE. Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism. Exp Biol Med (Maywood). 2012;237:1–9.
Article
CAS
Google Scholar
Bhushan B, Michalopoulos GK. Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor. Chem Biol Interact. 2020;324:109090.
Article
CAS
PubMed
Google Scholar
Wang H, Lafdil F, Kong X, Gao B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci. 2011;7:536–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology. 2004;40:1322–32.
Article
CAS
PubMed
Google Scholar
Vetelainen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg. 2007;245:44–50.
Article
PubMed
PubMed Central
Google Scholar
Oh SY, Park SK, Kim JW, Ahn YH, Park SW, Kim KS. Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver. J Biol Chem. 2003;278:28410–7.
Article
CAS
PubMed
Google Scholar
Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, et al. Peroxisome proliferator-activated receptor alpha activation induces hepatic steatosis, suggesting an adverse effect. PLoS One. 2014;9:e99245.
Article
PubMed
PubMed Central
CAS
Google Scholar
Komati R, Spadoni D, Zheng S, Sridhar J, Riley KE, Wang G. Ligands of Therapeutic Utility for the Liver X Receptors. Molecules. 2017;22:88.
Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem. 2001;276:4365–72.
Article
CAS
PubMed
Google Scholar
Zhai X, Yan K, Fan J, Niu M, Zhou Q, Zhou Y, et al. The beta-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol. 2013;169:197–212.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abiola M, Favier M, Christodoulou-Vafeiadou E, Pichard AL, Martelly I, Guillet-Deniau I. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One. 2009;4:e8509.
Article
PubMed
PubMed Central
CAS
Google Scholar
Huck I, Gunewardena S, Espanol-Suner R, Willenbring H, Apte U. Hepatocyte Nuclear Factor 4 Alpha Activation Is Essential for Termination of Liver Regeneration in Mice. Hepatology. 2019;70:666–81.
Article
CAS
PubMed
Google Scholar
Zhang Y, Wang L. Characterization of the mitochondrial localization of the nuclear receptor SHP and regulation of its subcellular distribution by interaction with Bcl2 and HNF4alpha. PLoS One. 2013;8:e68491.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li T, Chiang JY. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab Dispos. 2006;34:756–64.
Article
CAS
PubMed
Google Scholar
Yu KC, David C, Kadambi S, Stahl A, Hirata K, Ishida T, et al. Endothelial lipase is synthesized by hepatic and aorta endothelial cells and its expression is altered in apoE-deficient mice. J Lipid Res. 2004;45:1614–23.
Article
CAS
PubMed
Google Scholar
VerHague MA, Cheng D, Weinberg RB, Shelness GS. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol. 2013;33:2501–8.
Article
CAS
PubMed
Google Scholar
Shin MJ, Krauss RM. Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. Atherosclerosis. 2010;211:337–41.
Article
CAS
PubMed
Google Scholar
Kronenberg F, Stuhlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, von Eckardstein A, et al. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol. 2000;36:751–7.
Article
CAS
PubMed
Google Scholar
Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res. 2003;44:2374–81.
Article
CAS
PubMed
Google Scholar
Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. Species differences in bile acids I. Plasma and urine bile acid composition. J Appl Toxicol. 2018;38:1323–35.
Article
CAS
PubMed
Google Scholar
Chen JY, Levy-Wilson B, Goodart S, Cooper AD. Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J Biol Chem. 2002;277:42588–95.
Article
CAS
PubMed
Google Scholar
Ferrell JM, Boehme S, Li F, Chiang JY. Cholesterol 7alpha-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders. J Lipid Res. 2016;57:1144–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 2002;110:109–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. 1999;3:543–53.
Article
CAS
PubMed
Google Scholar
Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17:225–35.
Article
CAS
PubMed
Google Scholar
Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol. 2003;17:386–94.
Article
CAS
PubMed
Google Scholar
Bazhan N, Zelena D. Food-intake regulation during stress by the hypothalamo-pituitary-adrenal axis. Brain Res Bull. 2013;95:46–53.
Article
CAS
PubMed
Google Scholar
Shimizu N, Maruyama T, Yoshikawa N, Matsumiya R, Ma Y, Ito N, et al. A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling. Nat Commun. 2015;6:6693.
Article
CAS
PubMed
Google Scholar
Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A. 2004;101:7088–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Michailidou Z, Carter RN, Marshall E, Sutherland HG, Brownstein DG, Owen E, et al. Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet. FASEB J. 2008;22:3896–907.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mueller KM, Kornfeld JW, Friedbichler K, Blaas L, Egger G, Esterbauer H, et al. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. Hepatology. 2011;54:1398–409.
Article
CAS
PubMed
Google Scholar
Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, et al. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Clin Endocrinol. 2009;70:554–60.
Article
CAS
Google Scholar
Zou X, Ramachandran P, Kendall TJ, Pellicoro A, Dora E, Aucott RL, et al. 11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis. Hepatology. 2018;67:2167–81.
Article
CAS
PubMed
Google Scholar
Tamura Y, Kawao N, Yano M, Okada K, Okumoto K, Chiba Y, et al. Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice. Diabetes. 2015;64:2194–206.
Article
CAS
PubMed
Google Scholar
Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, et al. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner. Mol Pharmacol. 2010;78:135–41.
Article
CAS
PubMed
Google Scholar
Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, et al. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol. 1999;19:5495–503.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shi X, Shi W, Li Q, Song B, Wan M, Bai S, et al. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 2003;4:374–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou Y, Rui L. Lipocalin 13 regulation of glucose and lipid metabolism in obesity. Vitam Horm. 2013;91:369–83.
Article
PubMed
PubMed Central
CAS
Google Scholar
Berger JH, Charron MJ, Silver DL. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. PLoS One. 2012;7:e50629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aichem A, Groettrup M. The ubiquitin-like modifier FAT10 in cancer development. Int J Biochem Cell Biol. 2016;79:451–61.
Article
CAS
PubMed
Google Scholar
Langlais D, Couture C, Balsalobre A, Drouin J. The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol Cell. 2012;47:38–49.
Article
CAS
PubMed
Google Scholar
Schregle R, Mah MM, Mueller S, Aichem A, Basler M, Groettrup M. The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functions. Immunogenetics. 2018;70:429–38.
Article
CAS
PubMed
Google Scholar
Basler M, Buerger S, Groettrup M. The ubiquitin-like modifier FAT10 in antigen processing and antimicrobial defense. Mol Immunol. 2015;68:129–32.
Article
CAS
PubMed
Google Scholar
Choi Y, Kim JK, Yoo JY. NFkappaB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53. Mol Oncol. 2014;8:642–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Canaan A, DeFuria J, Perelman E, Schultz V, Seay M, Tuck D, et al. Extended lifespan and reduced adiposity in mice lacking the FAT10 gene. Proc Natl Acad Sci U S A. 2014;111:5313–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mork LM, Strom SC, Mode A, Ellis EC. Addition of Dexamethasone Alters the Bile Acid Composition by Inducing CYP8B1 in Primary Cultures of Human Hepatocytes. J Clin Exp Hepatol. 2016;6:87–93.
Article
PubMed
PubMed Central
Google Scholar
Oosterveer MH, Grefhorst A, van Dijk TH, Havinga R, Staels B, Kuipers F, et al. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem. 2009;284:34036–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zandbergen F, Mandard S, Escher P, Tan NS, Patsouris D, Jatkoe T, Rojas-Caro S, Madore S, Wahli W, Tafuri S, et al. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J. 2005;392:313–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao M, Bu L, Ma Y, Liu D. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice. PLoS One. 2013;8:e65641.
Article
CAS
PubMed
PubMed Central
Google Scholar
Holloway MG, Miles GD, Dombkowski AA, Waxman DJ. Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver. Mol Endocrinol. 2008;22:1274–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Della Torre S, Mitro N, Fontana R, Gomaraschi M, Favari E, Recordati C, et al. An Essential Role for Liver ERalpha in Coupling Hepatic Metabolism to the Reproductive Cycle. Cell Rep. 2016;15:360–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vandevyver S, Dejager L, Libert C. Comprehensive overview of the structure and regulation of the glucocorticoid receptor. Endocr Rev. 2014;35:671–93.
Article
CAS
PubMed
Google Scholar
Wortham M, Czerwinski M, He L, Parkinson A, Wan YJ. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos. 2007;35:1700–10.
Article
CAS
PubMed
Google Scholar
Yang Y, Zhou TC, Liu YY, Li X, Wang WX, Irwin DM, et al. Identification of HNF4A Mutation p.T130I and HNF1A Mutations p.I27L and p.S487N in a Han Chinese Family with Early-Onset Maternally Inherited Type 2 Diabetes. J Diabetes Res. 2016;2016:3582616.
PubMed
PubMed Central
Google Scholar
Granados-Silvestre MA, Ortiz-Lopez MG, Granados J, Canizales-Quinteros S, Penaloza-Espinosa RI, Lechuga C, et al. Susceptibility background for type 2 diabetes in eleven Mexican Indigenous populations: HNF4A gene analysis. Mol Gen Genomics. 2017;292:1209–19.
Article
CAS
Google Scholar
Huang KW, Reebye V, Czysz K, Ciriello S, Dorman S, Reccia I, et al. Liver Activation of Hepatocellular Nuclear Factor-4alpha by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile. Mol Ther Nucleic Acids. 2020;19:361–70.
Article
CAS
PubMed
Google Scholar
Schuler M, Dierich A, Chambon P, Metzger D. Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse. Genesis. 2004;39:167–72.
Article
CAS
PubMed
Google Scholar
Dif N, Euthine V, Gonnet E, Laville M, Vidal H, Lefai E. Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J. 2006;400:179–88.
Article
CAS
PubMed
PubMed Central
Google Scholar